Yu-Waye Chu

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Christopher Ogden, as Attorney-in-Fact for Yu-Waye Chu
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yu-Waye Chu:

Company Role Class Num Shares Value Price $ Report Date Ownership
CytomX Therapeutics, Inc. Chief Medical Officer Common Stock 210,725 $897,688 $4.26 02 Feb 2026 Direct
FATE THERAPEUTICS INC Chief Medical Officer Common Stock 140,676 $614,754 $4.37 18 Apr 2023 Direct
CytomX Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 300,000 02 Feb 2026 Direct
CytomX Therapeutics, Inc. Chief Medical Officer Performance Stock Units (PSUs) 43,750 26 Sep 2025 Direct

Insider Reports Filed by Yu-Waye Chu

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CTMX CytomX Therapeutics, Inc. 02 Feb 2026 2 $0 4 Chief Medical Officer 04 Feb 2026, 16:27
CTMX CytomX Therapeutics, Inc. 26 Sep 2025 2 $0 4 Chief Medical Officer 30 Sep 2025, 18:39
CTMX CytomX Therapeutics, Inc. 18 Mar 2025 1 -$2,411 4 Chief Medical Officer 20 Mar 2025, 16:32
CTMX CytomX Therapeutics, Inc. 04 Feb 2025 4 $0 4 Chief Medical Officer 06 Feb 2025, 17:55
CTMX CytomX Therapeutics, Inc. 18 Jan 2024 3 $0 4 Chief Medical Officer 19 Jan 2024, 20:37
CTMX CytomX Therapeutics, Inc. 19 Jul 2023 1 $0 4 Chief Medical Officer 20 Jul 2023, 17:18
CTMX CytomX Therapeutics, Inc. 19 Jul 2023 0 $0 3 Chief Medical Officer 20 Jul 2023, 17:17
FATE FATE THERAPEUTICS INC 18 Apr 2023 2 -$16,648 4 Chief Medical Officer 19 Apr 2023, 16:07
FATE FATE THERAPEUTICS INC 06 Feb 2023 1 $0 4 Chief Medical Officer 07 Feb 2023, 15:13
FATE FATE THERAPEUTICS INC 10 Jan 2023 1 -$41,003 4 Chief Medical Officer 11 Jan 2023, 15:05
FATE FATE THERAPEUTICS INC 19 Apr 2022 1 -$143,673 4 Chief Medical Officer 21 Apr 2022, 16:04
FATE FATE THERAPEUTICS INC 25 Jan 2022 2 $0 4 Chief Medical Officer 27 Jan 2022, 15:37
FATE FATE THERAPEUTICS INC 11 Jan 2022 2 -$192,340 4 Senior VP Clinical Development 13 Jan 2022, 15:05
FATE FATE THERAPEUTICS INC 10 Dec 2021 9 -$263,548 4 Senior VP Clinical Development 13 Dec 2021, 16:53
FATE FATE THERAPEUTICS INC 19 Nov 2021 1 $0 4 Senior VP Clinical Development 22 Nov 2021, 16:38